Concepedia

Publication | Open Access

Relation between changes in foveal choroidal thickness and 1-year results of ranibizumab therapy for polypoidal choroidal vasculopathy

19

Citations

25

References

2014

Year

Abstract

The subfoveal choroidal thickness decreased during ranibizumab therapy, which was associated with resolved polypoidal lesions and foveal retinal thickness, and may be associated with PCV activity.

References

YearCitations

2008

2.2K

2009

882

2011

764

2012

759

1994

628

1995

608

2012

585

2011

583

2020

495

2012

368

Page 1